Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · IEX Real-Time Price · USD
0.737
+0.001 (0.10%)
At close: Mar 27, 2024, 4:00 PM
0.710
-0.027 (-3.64%)
After-hours: Mar 27, 2024, 6:46 PM EDT

Monopar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2022202120202019
Market Capitalization
11304070173
Market Cap Growth
--24.61%-42.33%-59.48%-
Enterprise Value
3172053160
PE Ratio
-0.92-2.90-4.44-11.12-40.94
PB Ratio
1.683.022.134.4713.70
P/FCF Ratio
-1.15-4.21-5.52-15.03-57.32
P/OCF Ratio
-1.15-4.21-5.52-15.03-57.32
EV/EBITDA Ratio
-0.03-1.65-2.21-8.46-37.82
EV/EBIT Ratio
-0.03-1.65-2.21-8.46-37.82
EV/FCF Ratio
-0.04-2.40-2.75-11.44-52.95
Debt / Equity Ratio
-0.00---
Debt / EBITDA Ratio
-0.00---
Debt / FCF Ratio
-0.00---
Quick Ratio
4.294.1912.8514.2218.25
Current Ratio
4.324.2112.9814.2818.27
Return on Equity (ROE)
-113.30%-77.80%-41.10%-43.70%-60.00%
Return on Assets (ROA)
-86.20%-67.30%-39.00%-41.60%-55.60%
Return on Capital (ROIC)
-148.66%-104.35%-48.19%-41.48%-34.24%
Earnings Yield
-85.33%-34.51%-22.52%-9.00%-2.44%
FCF Yield
-68.50%-23.73%-18.11%-6.65%-1.74%
Buyback Yield / Dilution
-10.69%-1.98%-13.81%-17.56%-0.32%
Total Shareholder Return
-10.69%-1.98%-13.81%-17.56%-0.32%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).